Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nurix Therapeutics Inc shares valued at $84,388 were sold by van Houte Hans on Mar 03 ’25. At $14.49 per share, van Houte Hans sold 5,825 shares. The insider’s holdings dropped to 33,724 shares worth approximately $0.42 million following the completion of this transaction.
Also, JOHANNES VAN HOUTE purchased 5,825 shares, netting a total of over 89,996 in proceeds.
Before that, Ring Christine had sold 5,760 shares from its account. In a trade valued at $114,934, the Chief Legal Officer traded Nurix Therapeutics Inc shares for $19.95 each. Upon closing the transaction, the insider’s holdings decreased to 5,760 shares, worth approximately $0.41 million.
As published in their initiating research note from Leerink Partners on March 17, 2025, Nurix Therapeutics Inc [NRIX] has been a Market perform and the price target has been revised to $16. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of December 06, 2024, BMO Capital Markets has initiated its “an Outperform” rating for NRIX. Earlier on October 24, 2024, UBS initiated its rating. Their recommendation was “a Buy” for NRIX stock.
Analyzing NRIX Stock Performance
During the last five days, there has been a drop of approximately -9.52%. Over the course of the year, Nurix Therapeutics Inc shares have dropped approximately -33.39%. Shares of the company reached a 52-week high of $20.66 on 01/27/25 and a 52-week low of $12.20 on 03/26/25. A 50-day SMA is recorded $16.54, while a 200-day SMA reached $20.78.
Support And Resistance Levels for Nurix Therapeutics Inc (NRIX)
According to the 24-hour chart, there is a support level at 12.26, which, if violated, would cause prices to drop to 11.97. In the upper region, resistance lies at 12.97. The next price resistance is at 13.38. RSI (Relative Strength Index) is 32.85 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.83, which suggests the price will decrease in the coming days. Percent R is at 86.89%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
